Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression [8]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 5, 2006, Pages 542-544

  Tulen, Joke H M ^a   Volkers, Anita C ^a   Van Den Broek, Walter W ^a   Bruijn, Jan A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUVOXAMINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; TRANYLCYPROMINE;

ADULT; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFECT; FEMALE; HAMILTON SCALE; HUMAN; LETTER; MAJOR DEPRESSION; MALE; ORTHOSTATIC HYPOTENSION; PATIENT POSITIONING; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BLOOD PRESSURE; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; FLUVOXAMINE; HUMANS; HYPOTENSION, ORTHOSTATIC; IMIPRAMINE; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PHENELZINE; PSYCHIATRIC STATUS RATING SCALES; TRANYLCYPROMINE; TREATMENT OUTCOME;

EID: 33748754015     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000236657.08663.ae     Document Type: Letter

References (13)

1. Thase ME, Frank E, Mallinger AG, et al. Treatment of imipramine-resistant recurrent depression, III: efficacy of monoamine oxidase inhibitors. J Clin Psychiatry. 1992;53:5-11.
2. Birkenhager TK, van den Broek WW, Mulder PGH, et al. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. J Clin Psychiatry. 2004;65(11):1505-1510.
3. Rabkin JG, Quitkin FM, Harrison W, et al. Adverse reaction to monoamine oxidase inhibitors. Part I. A comparative study. J Clin Psychopharmacol. 1984;4:270-278.
4. Rabkin JG, Quitkin FM, McGrath P, et al. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management. J Clin Psychopharmacol. 1985;5:2-9.
5. Raskin A. Adverse reactions to phenelzine: results of a nine-hospital depression study. J Clin Pharmacol New Drugs. 1972;12:22-25.
6. Robinson DS, Nies A, Ravaris CL, et al. Clinical pharmacology of phenelzine. Arch Gen Psychiatry. 1978;35:629-635.
7. Kronig MH, Roose SP, Walsh BT, et al. Blood pressure effects of phenelzine. J Clin Psychopharmacol. 1983;3:307-310.
8. Georgotas A, McCue RE, Friedman E, Cooper TB. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients. J Clin Psychopharmacol. 1987;7:413-416.
9. O'Brien S, McKeon P, O'Regan M, et al. Blood pressure effects of tranylcypromine when prescribed singly and in combination with amitryptyline. J Clin Psychopharmacol. 1992;12:104-109.
10. Lin S-C, Hsu T, Fredrickson PA, Richelson E. Yohimbine- and tranylcypromine-induced postural hypotension. Am J Psychiatry. 1987;144:1.
11. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
12. Sheehan DV, Claycomb JB, Kouretas N. Monoamine oxidase inhibitors: prescription and patient management. Int J Psychiatry Med. 1980-1981;10:99-121.
13. McGrath PJ, Blood DK, Stewart JW, et al. A comparative study of the electrocardiographic effects of phenelzine, tricyclic anti-depressants, mianserin, and placebo. J Clin Psychopharmacol. 1987;7:335-339.